EKSPERTYZA WSTĘPNA - Ceestahc

Ekspertyza wstępna „Diagnostyka zmian nowotworowych narządu rodnego” Wersja 0.9 Strona 187/239
2799. [No authors listed];Population screening for cervical cancer in The Netherlands. A report by the Evaluation Committee;Int
J Epidemiol. 1989 Dec;18(4):775-81.
2800. Nasri MN, Coast GJ.;Correlation of ultrasound findings and endometrial histopathology in postmenopausal women;Br J
Obstet Gynaecol. 1989 Nov;96(11):1333-8.
2801. Thornton J, Chamberlain J.;Cervical screening in the workplace;Community Med. 1989 Nov;11(4):290-8.
2802. Meier W, Eiermann W, Stieber P, et. al.;Experiences with SCC antigen, a new tumor marker for cervical carcinoma;Eur
J Cancer Clin Oncol. 1989 Nov;25(11):1555-9.
2803. Wheelock JB, Kaminski PF.;Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial
neoplasia on Papanicolaou smears;J Reprod Med. 1989 Oct;34(10):815-7.
2804. Thorvinger B, Gudmundsson T, Horvath G, et. al.;Staging in local endometrial carcinoma. Assessment of magnetic
resonance and ultrasound examinations;Acta Radiol. 1989 Sep-Oct;30(5):525-9.
2805. Higgins RV, van Nagell JR Jr, Donaldson ES, et. al.;Transvaginal sonography as a screening method for ovarian cancer;Gynecol
Oncol. 1989 Sep;34(3):402-6.
2806. Chou P, Chen V.;Mass screening for cervical cancer in Taiwan from 1974 to 1984;Cancer. 1989 Aug 15;64(4):962-8.
2807. Hsieh CY, Chang DY, Huang SC, et. al.;Serum squamous cell carcinoma antigen in gynecologic malignancies with
special reference to cervical cancer;Taiwan Yi Xue Hui Za Zhi. 1989 Aug;88(8):797-800.
2808. Robertson AJ, Reid GS, Stoker CA, et. al.;Evaluation of a call programme for cervical cytology screening in women
aged 50-60;BMJ. 1989 Jul 15;299(6692):163-6.
2809. Pierce M, Lundy S, Palanisamy A, et. al.;Prospective randomised controlled trial of methods of call and recall for cervical
cytology screening;BMJ. 1989 Jul 15;299(6692):160-2.
2810. Beardow R, Oerton J, Victor C.;Evaluation of the cervical cytology screening programme in an inner city health district;BMJ.
1989 Jul 8;299(6691):98-100.
2811. Janus CL, Mendelson DS, Moore S, et. al.;Staging of cervical carcinoma: accuracy of magnetic resonance imaging and
computed tomography;Clin Imaging. 1989 Jun;13(2):114-6.
2812. Soothill PW, Alcock CJ, MacKenzie IZ.;Discrepancy between curettage and hysterectomy histology in patients with
stage 1 uterine malignancy;Br J Obstet Gynaecol. 1989 Apr;96(4):478-81.
2813. Hughes RG, Colquhoun M, Eccles DM, et. al.;Cervical intraepithelial neoplasia in lymphoma patients: a cytological and
colposcopic study;Br J Cancer. 1989 Apr;59(4):594-9.
2814. Yamamoto K, Kitao M.;The evaluation of transrectal radial ultrasonography on parametrial infiltration in untreated cervical
carcinoma for more accurate staging;Nippon Sanka Fujinka Gakkai Zasshi. 1989 Apr;41(4):487-94.
2815. de Schryver A.;Does screening for cervical cancer affect incidence and mortality trends? The Belgian experience;Eur J
Cancer Clin Oncol. 1989 Feb;25(2):395-9.
2816. van Driel-Kulker AM, Ploem-Zaaijer JJ.;Image cytometry in automated cervical screening;Anal Cell Pathol. 1989
Feb;1(1):63-77.
2817. Sigurdsson K, Adalsteinsson S, Tulinius H, et. al.;The value of screening as an approach to cervical cancer control in
Iceland, 1964-1986;Int J Cancer. 1989 Jan 15;43(1):1-5.
2818. Kornafel J, Wawrzkiewicz M.;Evaluation of diagnostic usefulness of CEA, hCG and SCC antigens in cervical cancer
patients;Eur J Gynaecol Oncol. 1989;10(5):319-22.
2819. Mogensen O, Mogensen B, Jakobsen A, et. al.;Preoperative measurement of cancer antigen 125 (CA 125) in the differential
diagnosis of ovarian tumors;Acta Oncol. 1989;28(4):471-3.
2820. De Schryver A, Derese A, Geldhof A, et. al.;Screening for cervical cancer by general practitioners in Ghent, Belgium;Cancer
Detect Prev. 1989;13(5-6):343-8.
2821. Zhang ZF, Parkin DM, Yu SZ, et. al.;Cervical screening attendance and its effectiveness in a rural population in
China;Cancer Detect Prev. 1989;13(5-6):337-42.
2822. Di Bonito L, Delendi M, Patriarca S, et. al.;Correlation between cervical intraepithelial neoplasia and invasive cervical
carcinoma on the basis of their frequency in the Province of Trieste (1977-1986);Eur J Gynaecol Oncol.
1989;10(2):147-52.
2823. Crombach G, Scharl A, Wurz H.;CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian
tube. II. Immunoradiometric determination in secretions, tissue extracts and serum;Arch Gynecol Obstet.
1989;244(2):113-22.
2824. Millo R, Facca MC, Alberico S.;Sonographic evaluation of ovarian volume in postmenopausal women: a screening test
for ovarian cancer?,Clin Exp Obstet Gynecol. 1989;16(2-3):72-8.
2825. Einhorn N, Knapp RC, Bast RC, et. al.;CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination
between malignant and non-malignant diseases of the ovary;Acta Oncol. 1989;28(5):655-7.
2826. Havelock CM, Webb J, Queenborough J.;Preliminary results of a district call scheme for cervical screening organised
in general practice;BMJ. 1988 Nov 26;297(6660):1384-6.
2827. MacCormac L, Lew W, King G, et. al.;Gynaecological cytology screening in South Australia: a 23-year experience;Med
J Aust. 1988 Nov 21;149(10):530-6.
2828. Chang YC, Hricak H, Thurnher S, et. al.;Vagina: evaluation with MR imaging. Part II. Neoplasms;Radiology. 1988
Oct;169(1):175-9.
2829. Finkler NJ, Benacerraf B, Lavin PT, et. al.;Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative
evaluation of ovarian masses;Obstet Gynecol. 1988 Oct;72(4):659-64.
2830. Sheth S, Fishman EK, Buck JL, et. al.;The variable sonographic appearances of ovarian teratomas: correlation with
CT;AJR Am J Roentgenol. 1988 Aug;151(2):331-4.
www.ceestahc.org